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Case

Introduction
• Hürthle cell carcinoma (HCC) is rare, accounting for 3% of
thyroid neoplasms.
•

It is more clinically aggressive compared to other
differentiated thyroid cancers.

• Though thoracic involvement has been documented, it has
rarely caused malignant pleural effusion.
• Here, we describe a case of metastatic HCC presenting with
dyspnea and recurrent unilateral pleural effusion.

• A 73-year-old male presented with dyspnea.
• Past medical history was significant for HCC of the thyroid
diagnosed in 2005 treated with thyroidectomy followed by
radioactive iodine ablation. Pathology was consistent with
widely invasive HCC with clear cell change.
• He remained asymptomatic until he developed dyspnea in
2015; CT chest showed increase in pulmonary nodule size.
• Biopsy revealed metastatic poorly differentiated thyroid
cancer. He underwent radiotherapy of the right upper
lobe and resection of left chest wall mass.
• He continued to have pleuritic chest pain. Imaging
showed a recurrent large left pleural effusion, requiring
thoracentesis with symptomatic relief.

Discussion
• Hurthle cell carcinoma is rare, aggressive form of cancer
with increased risk of recurrence.
• Local occurrence and metastatic disease could be found
in 30% patients over 20 years after total or subtotal
thyroidectomy.
• Pulmonary metastasis has been reported to be the most
common site, though its incidence is significantly less in
patients who were treated by total thyroidectomy.
•

Nevertheless, it is imperative to consider HCC
recurrence in patients presenting with dyspnea and
pleural effusion despite interventions.

• Patient underwent treatment with several chemotherapy
agents, complicated by side effects.
Figure 1. CT chest demonstrates
extensive pleural based masses in
left lung with loculated pleural
effusion producing near-complete
atelectasis of the left lung. Also
noted is shift of heart and
mediastinal structures to right.

Figure 2. CXR demonstrates
opacification of left hemithorax
with right shift of mediastinal
structures.

• He then developed left loculated pleural effusion and
subsegmental PE
• He continued to deteriorate with multiorgan failure.
Ultimately pursing home hospice.
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